OSU's kidney dialysis technology provider has added about $36m to close its initial public offering, its shares having more than doubled in price.

Outset Medical, the US-based dialysis technology producer advacing research from Oregon State University, closed its initial public offering at approximately $278m yesterday. The company floated on Wednesday, issuing 8.95 million shares on the Nasdaq Global Select Market at $27 each to raise an initial $242m. The shares, already priced above the IPO’s $22 to $24…

The rest of this content is only accessible to Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.